Has my stock been accused of fraud?Join over 160k users who know.

Ticker Price Change($) Change(%) Shares Volume Prev Close Open Gain($) Gain(%)
Ticker Status Jurisdiction Filing Date CP Start CP End CP Loss Deadline
Ticker Case Name Status CP Start CP End Deadline Settlement Amt
Ticker Name Date Analyst Firm Up/Down Target ($) Rating Change Rating Current

News

Wedbush Downgrades Avrobio to Neutral, Announces $2 Price Target

Author: Benzinga Newsdesk | July 12, 2023 11:40am
Wedbush analyst David Nierengarten downgrades Avrobio (NASDAQ:AVRO) from Outperform to Neutral and announces $2 price target.

Posted In: AVRO

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION

CORE Finalist